Drug intelligence / Profile preview

Salbutamol + Theophylline

Development stage
Unknown
Lead developer
GSK
Modality
Drug Delivery Systems
Administration
Oral
01

Overview

Salbutamol + theophylline is a combination medication primarily used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD)[5][7]. This combination leverages the complementary mechanisms of both drugs to provide enhanced bronchodilation. ## Mechanism of Action The combination works through two distinct but synergistic pathways: 1. **Salbutamol** (also known as albuterol) is a selective beta-2 adrenergic receptor agonist that relaxes bronchial smooth muscle, providing quick relief from bronchospasm[3][10]. 2. **Theophylline** is a methylxanthine that causes bronchodilation by increasing cellular cyclic AMP through a different mechanism than salbutamol[4][6]. When combined, these medications appear to have a synergistic effect, potentially allowing for lower doses of each component while maintaining or enhancing therapeutic efficacy[4]. ## Clinical Use This combination is primarily prescribed for: - Management of asthma symptoms - Treatment of chronic obstructive pulmonary disease (COPD) - Relief of bronchospasm ## Dosage The appropriate dosage depends on the patient's age, gender, medical history, and specific formulation[7]. The medication is typically available in tablet form, often with salbutamol at 2mg and theophylline at 100mg per dose[4]. ## Side Effects Common side effects include: - Nausea and vomiting - Stomach pain - Headaches - Restlessness - Trembling or shaking - Difficulty sleeping - Increased heart rate (tachycardia)[1][5] ## Research Findings Research on this combination has shown mixed results: - Some studies indicate that the combination may produce negative interactions, including tachycardia and reduced therapeutic function when administered at maximum oral dosage[1]. - Other research suggests patients with chronic bronchitis may benefit from the combination if steady-state theophylline concentrations of 15-20 mg/l are achieved[2]. - A study with 36 perennial asthmatics found the combination to be superior to individual components due to synergistic effects, with no added side effects[4]. The combination should be used with caution, particularly in patients with certain medical conditions such as thyroid disorders, high blood pressure, heart disease, or diabetes[3][5].

Other names
Theophylline Salbutamol Extended-release Tablet茶碱沙丁胺醇缓释片
02

Targets

PDE (Phosphodiesterase family)ADOR (Adenosine receptors)ADRB2 (β2)

Beyond the preview

Go deeper on Salbutamol + Theophylline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salbutamol + Theophylline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call